Agilon Health Analyst Ratings
RBC Capital Maintains Agilon Health(AGL.US) With Buy Rating, Maintains Target Price $3
RBC Capital Reaffirms Their Buy Rating on Agilon Health (AGL)
Wells Fargo Maintains Agilon Health(AGL.US) With Buy Rating, Cuts Target Price to $4
Truist Financial Maintains Agilon Health(AGL.US) With Hold Rating
Citi Maintains Agilon Health(AGL.US) With Sell Rating, Cuts Target Price to $1.75
Agilon Health Is Maintained at Underweight by Barclays
Agilon Health Analyst Ratings
TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Maintains Target Price $2
BTIG Maintains Agilon Health(AGL.US) With Hold Rating
Agilon Health Downgraded to Market Perform From Outperform at JMP Securities
JMP Securities Downgrades Agilon Health(AGL.US) to Hold Rating
TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Cuts Target Price to $2
Agilon Health (AGL) Gets a Sell From Barclays
BofA Securities Maintains Agilon Health(AGL.US) With Sell Rating
Deutsche Bank Adjusts Agilon Health Price Target to $2 From $4, Maintains Hold Rating
Agilon Health (AGL) Receives a Hold From Evercore ISI
TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Maintains Target Price $6
Agilon Health Analyst Ratings
RBC Capital Maintains Agilon Health(AGL.US) With Buy Rating, Cuts Target Price to $3